JPWO2022268152A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022268152A5 JPWO2022268152A5 JP2023579274A JP2023579274A JPWO2022268152A5 JP WO2022268152 A5 JPWO2022268152 A5 JP WO2022268152A5 JP 2023579274 A JP2023579274 A JP 2023579274A JP 2023579274 A JP2023579274 A JP 2023579274A JP WO2022268152 A5 JPWO2022268152 A5 JP WO2022268152A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- hydrogen
- halogen
- group
- pharma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110702643.0 | 2021-06-24 | ||
| CN202110702643 | 2021-06-24 | ||
| PCT/CN2022/100685 WO2022268152A1 (zh) | 2021-06-24 | 2022-06-23 | Glp-1受体激动剂及其组合物和用途 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024523525A JP2024523525A (ja) | 2024-06-28 |
| JP2024523525A5 JP2024523525A5 (https=) | 2025-06-27 |
| JPWO2022268152A5 true JPWO2022268152A5 (https=) | 2025-06-27 |
Family
ID=84544137
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023579274A Pending JP2024523525A (ja) | 2021-06-24 | 2022-06-23 | Ｇｌｐ－１受容体アゴニストならびにその組成物および使用 |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US11981666B2 (https=) |
| EP (1) | EP4361145A4 (https=) |
| JP (1) | JP2024523525A (https=) |
| KR (1) | KR20240024910A (https=) |
| CN (2) | CN117098758A (https=) |
| AU (1) | AU2022300055A1 (https=) |
| CA (1) | CA3219984A1 (https=) |
| CL (1) | CL2023003794A1 (https=) |
| CO (1) | CO2023017726A2 (https=) |
| CR (1) | CR20230611A (https=) |
| DO (1) | DOP2023000275A (https=) |
| EC (1) | ECSP23095307A (https=) |
| IL (1) | IL309235A (https=) |
| MX (1) | MX2023014985A (https=) |
| PE (1) | PE20241794A1 (https=) |
| TW (1) | TW202317553A (https=) |
| WO (1) | WO2022268152A1 (https=) |
| ZA (1) | ZA202400786B (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3157525A1 (en) | 2019-10-25 | 2021-04-29 | Gilead Sciences, Inc. | Glp-1r modulating compounds |
| PH12023552860A1 (en) | 2021-04-21 | 2024-05-20 | Gilead Sciences Inc | Carboxy-benzimidazole glp-1r modulating compounds |
| IL310377A (en) | 2021-08-30 | 2024-03-01 | Mindrank Ai Ltd | Novel aryl ether substituted heterocyclic compound as glp1r agonist |
| KR20240068737A (ko) | 2021-09-27 | 2024-05-17 | 테른스 파마슈티칼스, 인크. | Glp-1r 효능제로서의 벤즈이미다졸 카복실산 |
| AU2022375634A1 (en) | 2021-10-25 | 2024-06-06 | Terns Pharmaceuticals, Inc. | Compounds as glp-1r agonists |
| KR20240150488A (ko) | 2022-02-23 | 2024-10-15 | 테른스 파마슈티칼스, 인크. | Glp-1r 작용제로서의 화합물 |
| US20260097037A1 (en) | 2022-09-22 | 2026-04-09 | Shionogi & Co., Ltd. | Fused ring compound having glp-1 receptor agonist effect |
| CN120530106A (zh) * | 2022-12-13 | 2025-08-22 | 杭州中美华东制药有限公司 | Glp-1受体激动剂的新晶型和制备方法及其药物组合物和用途 |
| TW202440556A (zh) * | 2022-12-13 | 2024-10-16 | 中國大陸商杭州中美華東製藥有限公司 | 鹽型的glp-1受體激動劑、其晶型和製備方法及其藥物組合物和用途 |
| CN118496200A (zh) * | 2023-02-14 | 2024-08-16 | 成都康弘药业集团股份有限公司 | 吲唑啉酮类化合物及其制备方法和用途 |
| US20240398794A1 (en) | 2023-04-07 | 2024-12-05 | Terns Pharmaceuticals, Inc. | COMBINATIONS OF GLP-1R AND THRß AGONISTS AND METHODS OF USE THEREOF |
| TW202504600A (zh) | 2023-07-04 | 2025-02-01 | 大陸商杭州中美華東製藥有限公司 | Glp1r激動劑及其中間體的製備方法 |
| TW202521533A (zh) | 2023-09-14 | 2025-06-01 | 香港商歌禮製藥(中國)有限公司 | Glp-1r 激動劑及其治療方法 |
| US12291530B1 (en) | 2023-11-24 | 2025-05-06 | Ascletis Pharma (China) Co., Limited | GLP-1R agonist and therapeutic method thereof |
| WO2025158275A1 (en) | 2024-01-24 | 2025-07-31 | Pfizer Inc. | Combination therapy using glucose-dependent insulinotropic polypeptide receptor antagonist compounds and glp-1 receptor agonist compounds |
| WO2025189141A1 (en) | 2024-03-08 | 2025-09-12 | Annapurna Bio, Inc. | Methods for treating obesity and increasing weight loss |
| WO2025252098A1 (zh) * | 2024-06-05 | 2025-12-11 | 杭州中美华东制药有限公司 | Glp-1受体激动剂的口服药物组合物及其制备方法 |
| KR20260032385A (ko) * | 2024-08-28 | 2026-03-09 | 주식회사유한양행 | Glp-1 수용체 효능제 활성을 가진 시에노이미다졸 화합물, 이의 제조 방법, 및 이들의 의약 용도 |
| CN119837849B (zh) * | 2025-02-10 | 2025-06-13 | 中国科学院北京基因组研究所(国家生物信息中心) | 蜡菊素在制备缓解和治疗受试者细胞红系分化障碍的药物中的应用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7727983B2 (en) | 2008-03-07 | 2010-06-01 | Transtech Pharma, Inc. | Oxadiazoanthracene compounds for the treatment of diabetes |
| JP5755217B2 (ja) | 2009-03-30 | 2015-07-29 | トランステック・ファーマ，エルエルシー | 置換アゾアントラセン誘導体、その医薬組成物とその使用の方法 |
| US10723699B2 (en) | 2015-11-04 | 2020-07-28 | Hyundai Pharm Co., Ltd. | Cyclohexene derivative, preparation method thereof, and pharmaceutical composition for preventing or treating metabolic disease comprising the same as active ingredient |
| JOP20190060A1 (ar) | 2016-09-26 | 2019-03-26 | Chugai Pharmaceutical Co Ltd | مشتق بيرازولو بيريدين له تأثير مساعد لمستقبل glp-1 |
| EP3555064B9 (en) | 2016-12-16 | 2023-03-01 | Pfizer Inc. | Glp-1 receptor agonists and uses thereof |
| KR101910586B1 (ko) | 2017-03-03 | 2018-10-23 | 한국화학연구원 | 헤테로아릴이 치환된 2-페닐이미다조[1,2-a]피리딘 유도체, 이의 제조방법 및 이를 유효성분으로 포함하는 GLP-1 수용체 활성 관련 질환의 예방 또는 치료용 약학적 조성물 |
| CR20210341A (es) * | 2018-11-22 | 2021-11-25 | Qilu Regor Therapeutics Inc | Agonistas de glp-ir y usos de los mismos |
| AU2020256647B2 (en) * | 2019-04-12 | 2025-07-31 | Qilu Regor Therapeutics Inc. | GLP-1R agonists and uses thereof |
| WO2021018023A1 (zh) * | 2019-08-01 | 2021-02-04 | 济南泰达领创医药技术有限公司 | 小分子glp-1受体调节剂 |
| CA3157525A1 (en) * | 2019-10-25 | 2021-04-29 | Gilead Sciences, Inc. | Glp-1r modulating compounds |
| WO2021160127A1 (en) * | 2020-02-13 | 2021-08-19 | Gasherbrum Bio, Inc. | Heterocyclic glp-1 agonists |
| WO2022068772A1 (zh) * | 2020-09-29 | 2022-04-07 | 深圳信立泰药业股份有限公司 | 一种苯并咪唑类衍生物及其制备方法和医药用途 |
| EP4247804A1 (en) * | 2020-11-20 | 2023-09-27 | Gilead Sciences, Inc. | Polyheterocyclic glp-1 r modulating compounds |
| WO2022225914A1 (en) * | 2021-04-21 | 2022-10-27 | Gilead Sciences, Inc. | Carboxy-benzimidazole glp-1r modulating compounds |
-
2022
- 2022-06-23 WO PCT/CN2022/100685 patent/WO2022268152A1/zh not_active Ceased
- 2022-06-23 CN CN202280018027.6A patent/CN117098758A/zh active Pending
- 2022-06-23 EP EP22827644.0A patent/EP4361145A4/en active Pending
- 2022-06-23 AU AU2022300055A patent/AU2022300055A1/en active Pending
- 2022-06-23 JP JP2023579274A patent/JP2024523525A/ja active Pending
- 2022-06-23 PE PE2023003275A patent/PE20241794A1/es unknown
- 2022-06-23 CR CR20230611A patent/CR20230611A/es unknown
- 2022-06-23 CA CA3219984A patent/CA3219984A1/en active Pending
- 2022-06-23 KR KR1020247001274A patent/KR20240024910A/ko active Pending
- 2022-06-23 TW TW111123462A patent/TW202317553A/zh unknown
- 2022-06-23 MX MX2023014985A patent/MX2023014985A/es unknown
- 2022-06-23 CN CN202311318579.1A patent/CN117362283B/zh active Active
- 2022-06-23 IL IL309235A patent/IL309235A/en unknown
-
2023
- 2023-09-13 US US18/367,517 patent/US11981666B2/en active Active
- 2023-12-14 DO DO2023000275A patent/DOP2023000275A/es unknown
- 2023-12-18 CO CONC2023/0017726A patent/CO2023017726A2/es unknown
- 2023-12-19 CL CL2023003794A patent/CL2023003794A1/es unknown
- 2023-12-19 EC ECSENADI202395307A patent/ECSP23095307A/es unknown
-
2024
- 2024-01-23 ZA ZA2024/00786A patent/ZA202400786B/en unknown
- 2024-03-22 US US18/613,714 patent/US20240360110A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2022268152A5 (https=) | ||
| JP2018517746A5 (https=) | ||
| RU2477723C2 (ru) | Ингибиторы протеинкиназ (варианты), их применение для лечения онкологических заболеваний и фармацевтическая композиция на их основе | |
| RU2317294C2 (ru) | (имидазол-1-илметил)пиридазин в качестве блокатора nmda рецептора | |
| JP2021523221A5 (https=) | ||
| JP2011509309A5 (https=) | ||
| RU2011103741A (ru) | Композиции и способы лечения заболевания сетчатки | |
| JP2012509903A5 (https=) | ||
| JP2018517752A5 (https=) | ||
| JP2007523155A5 (https=) | ||
| JP2016040288A5 (https=) | ||
| JP2020528938A5 (https=) | ||
| RU2010134411A (ru) | Фенилацетамидное производное | |
| AR056155A1 (es) | Antagonistas del receptor 1 de la hormona de concentracion de melanina no basica | |
| CN103108633A (zh) | TrkB激动剂及其用途 | |
| JP2020517619A5 (https=) | ||
| JP2009541387A5 (https=) | ||
| RU2007116987A (ru) | Новые соединения | |
| RU2007144076A (ru) | Новое производное лактама | |
| JP2010504321A5 (https=) | ||
| RU2009128968A (ru) | Производные изосорбидмононитрата для лечения повышенной внутриглазной гипертензии | |
| JP2004525905A5 (https=) | ||
| RU2013127611A (ru) | Модуляторы глюкагонового рецептора | |
| JP2021534254A5 (ja) | 心臓弁疾患を治療するための医薬組成物 | |
| CA2608163A1 (en) | Hydralazine compositions and methods |